190 related articles for article (PubMed ID: 18783742)
21. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
22. Survival in systemic lupus erythematosus.
Ridley MG; Long PJ; Hughes GR
Br J Hosp Med; 1988 Mar; 39(3):237-41. PubMed ID: 3282590
[TBL] [Abstract][Full Text] [Related]
23. Management of systemic lupus erythematosus in Chinese patients.
Mok CC
Expert Rev Clin Immunol; 2007 Nov; 3(6):925-35. PubMed ID: 20477141
[TBL] [Abstract][Full Text] [Related]
24. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
[TBL] [Abstract][Full Text] [Related]
25. Challenges for lupus management in emerging countries.
Tazi Mezalek Z; Bono W
Presse Med; 2014 Jun; 43(6 Pt 2):e209-20. PubMed ID: 24857588
[TBL] [Abstract][Full Text] [Related]
26. Active and latent tuberculosis in patients with systemic lupus erythematosus living in the United States.
Chu AD; Polesky AH; Bhatia G; Bush TM
J Clin Rheumatol; 2009 Aug; 15(5):226-9. PubMed ID: 19590444
[TBL] [Abstract][Full Text] [Related]
27. Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus.
Jeong SJ; Choi H; Lee HS; Han SH; Chin BS; Baek JH; Kim CO; Choi JY; Song YG; Kim JM
Scand J Infect Dis; 2009; 41(4):268-74. PubMed ID: 19172435
[TBL] [Abstract][Full Text] [Related]
28. The clinical importance of lymphadenopathy in systemic lupus erythematosus.
Melikoglu MA; Melikoglu M
Acta Reumatol Port; 2008; 33(4):402-6. PubMed ID: 19107085
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus.
Baizabal-Carvallo JF; Delgadillo-Márquez G; Estañol B; García-Ramos G
Eur Neurol; 2009; 61(3):143-8. PubMed ID: 19092250
[TBL] [Abstract][Full Text] [Related]
30. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis.
Fessler BJ
Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):281-91. PubMed ID: 12041954
[TBL] [Abstract][Full Text] [Related]
31. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset.
Romero-Díaz J; García-Sosa I; Sánchez-Guerrero J
J Rheumatol; 2009 Jan; 36(1):68-75. PubMed ID: 19012362
[TBL] [Abstract][Full Text] [Related]
32. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort.
Peschken CA; Katz SJ; Silverman E; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga HO; Gladman DD; Urowitz M; Zummer M; Clarke A; Bernatsky S; Hudson M;
J Rheumatol; 2009 Jun; 36(6):1200-8. PubMed ID: 19369456
[TBL] [Abstract][Full Text] [Related]
33. Mortality patterns in childhood lupus--10 years' experience in a developing country.
Singh S; Devidayal ; Kumar L; Joshi K
Clin Rheumatol; 2002 Nov; 21(6):462-5. PubMed ID: 12447628
[TBL] [Abstract][Full Text] [Related]
34. The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients.
Zhou WJ; Yang CD
Lupus; 2009 Aug; 18(9):807-12. PubMed ID: 19578105
[TBL] [Abstract][Full Text] [Related]
35. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
[TBL] [Abstract][Full Text] [Related]
36. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
37. Osteoporosis in patients with systemic lupus erythematosus.
García-Carrasco M; Mendoza-Pinto C; Escárcega RO; Jiménez-Hernández M; Etchegaray Morales I; Munguía Realpozo P; Rebollo-Vázquez J; Soto-Vega E; Delezé M; Cervera R
Isr Med Assoc J; 2009 Aug; 11(8):486-91. PubMed ID: 19891237
[TBL] [Abstract][Full Text] [Related]
38. Infections as triggers and complications of systemic lupus erythematosus.
Doria A; Canova M; Tonon M; Zen M; Rampudda E; Bassi N; Atzeni F; Zampieri S; Ghirardello A
Autoimmun Rev; 2008 Oct; 8(1):24-8. PubMed ID: 18703174
[TBL] [Abstract][Full Text] [Related]
39. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.
Martinez-Valle F; Balada E; Ordi-Ros J; Bujan-Rivas S; Sellas-Fernandez A; Vilardell-Tarres M
Lupus; 2009 Apr; 18(5):418-23. PubMed ID: 19318394
[TBL] [Abstract][Full Text] [Related]
40. The management of pediatric systemic lupus erythematosus.
Ardoin SP; Schanberg LE
Nat Clin Pract Rheumatol; 2005 Dec; 1(2):82-92. PubMed ID: 16932637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
